Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic
Description
CONCLUSIONS AND RELEVANCE: In this retrospective cohort study, a period of underdiagnosis and increase in stage IV disease was observed for HRGI cancers during the pandemic; however, there was no change in 1-year survival or operative mortality
